CVC  Eli Lilly and Company

https://www.lilly.com/partners





     Office Locations:

Lilly Corporate Center
Indianapolis, IN 46285
Phone: 800-545-5979

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War. As of 2022, Lilly is known for its clinical depression drugs Prozac (fluoxetine) (1986) and Cymbalta (duloxetine) (2004) and antipsychotic medication Zyprexa (olanzapine) (1996), though its primary revenue drivers are diabetes drugs Humalog (insulin lispro) (1996) and Trulicity (dulaglutide) (2014). Eli Lilly and Company (NYSE: LLY) today announced (January 2021) a $30 million limited partner investment in Unseen Capital Health Fund LP, a newly-formed venture fund created by racially diverse and historically underrepresented business leaders. For over 140 years, 100 medicines have been discovered.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Hadrian Szpurka Senior Director
    Katie Hewitt Chief Business Officer
    Leigh Ann Pusey Executive Vice President

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/13/2024


      Zephyr


      TX


      $111,000,000


      Series A


      11/07/2023


      OrsoBio


      


      $60,000,000


      Series A


      09/07/2023


      Mariana Oncology


      MA


      $175,000,000


      Series B


      08/03/2023


      Amber Bio


      CA


      $26,000,000


      Seed


      06/22/2023


      AltPep


      WA


      $52,900,000


      Series B


     

    Portfolio companies include:

     

    Recent News: